Clinical Outcomes and Treatment After Drug-Eluting Stent Failure | Zendy

Gabriel Maluenda | Zendy; Itsik BenDor | Zendy; Michael A. Gaglia | Zendy; Kohei Wakabayashi | Zendy; Michael Mahmoudi | Zendy; Gabriel Sardi | Zendy; Ana LaynezCarnicero | Zendy; Rebecca Torguson | Zendy; Zhenyi Xue | Zendy; Adrian D. Margulies | Zendy; William O. Suddath | Zendy; Kenneth M. Kent | Zendy; Nelson L. Bernardo | Zendy; Lowell F. Satler | Zendy; Augusto D. Pichard | Zendy; Ron Waksman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Outcomes and Treatment After Drug-Eluting Stent Failure

Author(s) -

Gabriel Maluenda,

Itsik BenDor,

Michael A. Gaglia,

Kohei Wakabayashi,

Michael Mahmoudi,

Gabriel Sardi,

Ana LaynezCarnicero,

Rebecca Torguson,

Zhenyi Xue,

Adrian D. Margulies,

William O. Suddath,

Kenneth M. Kent,

Nelson L. Bernardo,

Lowell F. Satler,

Augusto D. Pichard,

Ron Waksman

Publication year - 2012

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.111.963215

Subject(s) - medicine , restenosis , angioplasty , brachytherapy , stent , cardiology , revascularization , surgery , target lesion , myocardial infarction , population , hazard ratio , bypass surgery , percutaneous coronary intervention , radiation therapy , artery , confidence interval , environmental health

The optimal percutaneous treatment of drug-eluting stent (DES) in-stent restenosis (ISR) and the correlates for recurrent DES ISR remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research